NCT04868825

Brief Summary

long-term safety and performance of Ivory Dentin Graft. Ivory Dentin Graft is at least as good as the competitor treatment group (OsteoBiol Gen-Os) for alveolar ridge preservation following tooth extraction.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 7, 2017

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

April 20, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 3, 2021

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

May 3, 2021

Status Verified

April 1, 2021

Enrollment Period

7.2 years

First QC Date

April 20, 2021

Last Update Submit

April 27, 2021

Conditions

Keywords

Bone substitutesDental implantsDentin

Outcome Measures

Primary Outcomes (2)

  • Success of implant placement in a rigid post grafting site

    defined by dental implant survival

    5 years after grafting

  • Number of Participants with Treatment-Related Adverse Events

    through study completion

    5 years after grafting

Study Arms (2)

Experimental (Intervention)

EXPERIMENTAL
Device: Ivory Dentin Graft

Active Comparator

ACTIVE COMPARATOR
Device: OsteoBiol Gen-Os

Interventions

Ivory Dentin Graft is a bone graft material for the repair or augmentation of bone defects in dental procedures. It consists of sterile 300 - 900 μm porous particles or granules of hydroxyapatite and collagen which retain the natural form of the source porcine dentin and protein matrix. (Packed Vial: 1.00 gr; Packed Syringe: 1.0 gr)

Experimental (Intervention)

Comparator control device A natural porcine origin cortico-cancellous heterologous bone mix consists of sterile 250 - 1000 μm porous particles of hydroxyapatite and collagen (Packed Vial: 1.0 gr)

Active Comparator

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female patient 18 up to 80 years.
  • Patient requiring at least one implant placement following mandibular pre-molar or molar tooth extraction.
  • Alveolar mandibular ridge (empty socket):
  • Height: not less than 10 mm, from the gingival margin to the mandibular nerve canal - as seen in the screening CT scan.
  • Width: not less than 5 mm, from buccal to lingual cortical plates - as seen in the screening CT scan.
  • Ability to give informed consent for the study by patient or legal guardian.
  • Willingness to undergo 7 follow up visits: 1 week, 1, 4, 6 and 10 months, 2.5 years and 5 years following dental graft implantation, as well as unscheduled sick visits.

You may not qualify if:

  • Pregnancy (all women of childbearing age would be questioned and told by the consenting physician regarding that criteria).
  • Known or suspected hypersensitivity to the constituents of the bone graft material (for example porcine collagen)
  • Pathologies or conditions contraindicating surgery or presenting with active acute or chronic infections excluding periapical granuloma (for example osteomyelitis, sinusitis), uncontrolled diabetes
  • Immunologic disorders or autoimmune pathologies, in particular elderly
  • Serious bone diseases of endocrine aetiology
  • Serious disturbances of bone metabolism
  • Ongoing treatment with gluco- or mineralocorticoids, or with agents affecting calcium metabolism (e.g. calcitonin, bisphosphonates)
  • Irradiation therapy, chemotherapy or immunosuppressive therapy in the last 5 years
  • Malignancies
  • Severe Parafunction (bruxism and clenching)
  • Poor oral hygiene or active periodontitis
  • Heavy tobacco smoking habit (\> 10 cigarettes per day)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assaf HaRofeh Medical Center

Zrifin, 70300, Israel

Location

Related Publications (12)

  • Hansson S, Halldin A. Alveolar ridge resorption after tooth extraction: A consequence of a fundamental principle of bone physiology. J Dent Biomech. 2012;3:1758736012456543. doi: 10.1177/1758736012456543. Epub 2012 Aug 16.

    PMID: 22924065BACKGROUND
  • Horowitz R, Holtzclaw D, Rosen PS. A review on alveolar ridge preservation following tooth extraction. J Evid Based Dent Pract. 2012 Sep;12(3 Suppl):149-60. doi: 10.1016/S1532-3382(12)70029-5.

    PMID: 23040345BACKGROUND
  • Avila-Ortiz G, Chambrone L, Vignoletti F. Effect of alveolar ridge preservation interventions following tooth extraction: A systematic review and meta-analysis. J Clin Periodontol. 2019 Jun;46 Suppl 21:195-223. doi: 10.1111/jcpe.13057. Erratum In: J Clin Periodontol. 2020 Jan;47(1):129. doi: 10.1111/jcpe.13212.

    PMID: 30623987BACKGROUND
  • Chrcanovic BR, Albrektsson T, Wennerberg A. Bone Quality and Quantity and Dental Implant Failure: A Systematic Review and Meta-analysis. Int J Prosthodont. 2017 May/June;30(3):219-237. doi: 10.11607/ijp.5142. Epub 2017 Mar 20.

    PMID: 28319206BACKGROUND
  • Herrmann I, Lekholm U, Holm S, Kultje C. Evaluation of patient and implant characteristics as potential prognostic factors for oral implant failures. Int J Oral Maxillofac Implants. 2005 Mar-Apr;20(2):220-30.

    PMID: 15839115BACKGROUND
  • Barone A, Todisco M, Ludovichetti M, Gualini F, Aggstaller H, Torres-Lagares D, Rohrer MD, Prasad HS, Kenealy JN. A prospective, randomized, controlled, multicenter evaluation of extraction socket preservation comparing two bovine xenografts: clinical and histologic outcomes. Int J Periodontics Restorative Dent. 2013 Nov-Dec;33(6):795-802. doi: 10.11607/prd.1690.

    PMID: 24116363BACKGROUND
  • Mahesh L, Venkataraman N, Shukla S, Prasad H, Kotsakis GA. Alveolar ridge preservation with the socket-plug technique utilizing an alloplastic putty bone substitute or a particulate xenograft: a histological pilot study. J Oral Implantol. 2015 Apr;41(2):178-83. doi: 10.1563/AAID-JOI-D-13-00025. Epub 2013 Jun 17.

    PMID: 23772806BACKGROUND
  • Lai VJ, Michalek JE, Liu Q, Mealey BL. Ridge preservation following tooth extraction using bovine xenograft compared with porcine xenograft: A randomized controlled clinical trial. J Periodontol. 2020 Mar;91(3):361-368. doi: 10.1002/JPER.19-0211. Epub 2019 Aug 23.

    PMID: 31380563BACKGROUND
  • Pang C, Ding Y, Zhou H, Qin R, Hou R, Zhang G, Hu K. Alveolar ridge preservation with deproteinized bovine bone graft and collagen membrane and delayed implants. J Craniofac Surg. 2014 Sep;25(5):1698-702. doi: 10.1097/SCS.0000000000000887.

    PMID: 25148644BACKGROUND
  • Jung RE, Sapata VM, Hammerle CHF, Wu H, Hu XL, Lin Y. Combined use of xenogeneic bone substitute material covered with a native bilayer collagen membrane for alveolar ridge preservation: A randomized controlled clinical trial. Clin Oral Implants Res. 2018 May;29(5):522-529. doi: 10.1111/clr.13149. Epub 2018 Apr 1.

    PMID: 29607553BACKGROUND
  • Meloni SM, Tallarico M, Lolli FM, Deledda A, Pisano M, Jovanovic SA. Postextraction socket preservation using epithelial connective tissue graft vs porcine collagen matrix. 1-year results of a randomised controlled trial. Eur J Oral Implantol. 2015 Spring;8(1):39-48.

    PMID: 25738178BACKGROUND
  • Lee JS, Cha JK, Kim CS. Alveolar ridge regeneration of damaged extraction sockets using deproteinized porcine versus bovine bone minerals: A randomized clinical trial. Clin Implant Dent Relat Res. 2018 Oct;20(5):729-737. doi: 10.1111/cid.12628. Epub 2018 Jul 27.

    PMID: 30051954BACKGROUND

Study Officials

  • Tal Lavi, PhD

    Ivory Graft Ltd.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Only the graft performing sub-investigator and the study coordinator are un-blinded to subjects allocation - semi double blinded study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: prospective, randomized, semi double blinded with blinded assessments study comparing patients grafted with Ivory Dentin Graft (study arm) and patients grafted with OsteoBiol Gen Os (control arm) for alveolar ridge preservation following tooth extraction.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 20, 2021

First Posted

May 3, 2021

Study Start

November 7, 2017

Primary Completion

January 10, 2025

Study Completion

April 1, 2025

Last Updated

May 3, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

IPD is not intended to be shared as this will be a single site study. The study will be public at ClinicalTrial.gov

Locations